Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Marilyn Raney"'
Autor:
O J Martelo, George A. Omura, Marilyn Raney, Alfred A. Bartolucci, D S Gordon, William R. Vogler
Publikováno v:
American Journal of Clinical Oncology. 15:61-68
One hundred ninety-two evaluable patients were treated on a multicenter protocol for adult acute lymphoid leukemia to determine in a prospective randomized fashion if late intensification chemotherapy beginning after about six months of treatment wou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438f6765d65b904197df79c90b1a798e
https://doi.org/10.1097/00000421-199202000-00012
https://doi.org/10.1097/00000421-199202000-00012
Autor:
Winton Ef, Harvey J. Cohen, William R. Vogler, Marilyn Raney, Alfred A. Bartolucci, Richard S. Stein
Publikováno v:
Leukemia Research. 14:895-903
In a randomized trial, 299 evaluable patients with acute myelogenous leukemia, age greater than or equal to 51, were initially randomized to cytosine arabinoside, 100 mg/m2/day, by continuous intravenous infusion for seven days, plus either daunorubi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7cf57e2ace324abc8ee51e3d2870301
https://doi.org/10.1016/0145-2126(90)90179-d
https://doi.org/10.1016/0145-2126(90)90179-d
Autor:
Marilyn Raney, George A. Omura
Publikováno v:
Journal of Clinical Oncology. 3:1053-1058
Current observation was obtained for adults treated on a protocol for acute lymphoblastic leukemia, which was open from 1972 to 1978, in order to determine the long-term outcome and to evaluate potential prognostic factors. Long-term survival (five +
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35631a9633a19048f9e2e81683dabb9
https://doi.org/10.1200/jco.1985.3.8.1053
https://doi.org/10.1200/jco.1985.3.8.1053
Autor:
G. Battistini, Jody A. Storch, C. Caroti, T. Meggiato, G. Piot, G.J. Köteles, Howard W. Bruckner, G. Canavese, V. Zamrazil, Yvan de Launoit, H. Lupera, M. Pechová, T. Kubasova, Melvin Spigelman, A. Catturich, J. Němec, Marion C. Baker, Jean Lambert Pasteels, R. Naccarato, Niels B. Atkin, Robert Paridaens, S. Elba, D. Amoroso, D. Szeinfeld, G. Bertelli, Anne McKenna, Marilyn Raney, Robert Kiss, Aharon Lurie, P. Lapleige, D. Basso, C. Fabris, Alan P. Lyss, S. Zizzari, Mira Barak, M. Horváth, G. Del Favero, Manfred Kindler, Lawrence H. Einhorn, M. Soutorová, Dan W. Luedke, Jill Kalman, M. Neradilová, C.S. Beke, F. Di Mario, P.F. Conte, Nachman Gruener, G. Leandro, André Danguy, Mayer I. Gorbaty, G. Gardin, O.G. Manghisi, I. Szarvas, Susan L. Luedke, F. Badellino, Günter Steinhoff, C. Angonese, J. Bednář, S. Tomao, Yoel Mecz, P. Fargeot, Nina Butwell, P. Pronzato, C. Theodore, J.P. Droz
Publikováno v:
Oncology. 46:I-VI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc83e765a931c0feac0f3591ee64327d
https://doi.org/10.1159/000226748
https://doi.org/10.1159/000226748
Autor:
Richard A. Gams, Alfred A. Bartolucci, George A. Omura, Enrique Velez-Garcia, Robert W. Kellermeyer, Marilyn Raney
Publikováno v:
Cancer. 58:1963-1968
The Southeastern Cancer Study Group has explored the use of alternating sequential combination chemotherapy in advanced Hodgkin's disease. Two hundred twelve evaluable patients were randomly assigned to treatment with the six-drug combination, BCNU,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd0b61036f4cb24fddd60ca466b03049
https://doi.org/10.1002/1097-0142(19861101)58:9<1963::aid-cncr2820580902>3.0.co
https://doi.org/10.1002/1097-0142(19861101)58:9<1963::aid-cncr2820580902>3.0.co
Autor:
William R. Vogler, Marilyn Raney
Publikováno v:
Cancer. 61:2481-2486
Bone marrow and peripheral blood findings at the time of complete remission were analyzed in 333 patients with acute myelogenous leukemia to determine if any variables were predictive for remission duration and survival. Patients were categorized as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f5d0d1830acb20368f7c622a05240b3
https://doi.org/10.1002/1097-0142(19880615)61:12<2481::aid-cncr2820611216>3.0.co
https://doi.org/10.1002/1097-0142(19880615)61:12<2481::aid-cncr2820611216>3.0.co
Autor:
Marilyn Raney, Charles M. Huguley, William H. Knospe, James W. Keller, Alfred A. Bartolucci, George A. Omura, Lorraine Johnson
Publikováno v:
Cancer. 58:1185-1192
Patients with untreated chronic lymphocytic leukemia (CLL) received protocol treatment with 6 months of chlorambucil (CB) (30 mg/M2) and prednisone (P) (80 mg/d × 5) every 2 weeks. Complete and partial responders (CR, PR) were then randomized to con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c4f20b1816643436534ef4f75f0f2ae
https://doi.org/10.1002/1097-0142(19860915)58:6<1185::aid-cncr2820580602>3.0.co
https://doi.org/10.1002/1097-0142(19860915)58:6<1185::aid-cncr2820580602>3.0.co
Publikováno v:
Oncology. 46:357-359
64 eligible women with previously treated metastatic breast cancer received mitomycin C plus vindesine chemotherapy. Dosage was based on investigators' estimate of patients' bone marrow reserve. There were 19 evaluable patients in the good marrow res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f7fd673562c987198ffb670fe8e58bc
https://doi.org/10.1159/000226750
https://doi.org/10.1159/000226750
Publikováno v:
Investigational new drugs. 6(1)
The Southeastern Cancer Study Group performed a Phase II study of teniposide in previously treated patients with metastatic breast cancer. No responses were observed in 11 evaluable patients who received teniposide 60 mg/m2 by IV infusion for five co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ac1b16a4edc1ac96cb14164e524e05
https://pubmed.ncbi.nlm.nih.gov/3410666
https://pubmed.ncbi.nlm.nih.gov/3410666
Autor:
Elliott F. Winton, W. Ralph Vogler, Marilyn Raney, Roy S. Weiner, Gerald J. Elfenbein, Donald C. Shina, Barnett S. Kramer
Publikováno v:
Minimal Residual Disease in Acute Leukemia 1986 ISBN: 9789401083980
Therapeutic results for patients with acute myelogenous leukemia have improved dramatically over the past decade. The effective use of cytosine arabinoside (Ara-C) combined with anthracycline antibiotics as induction therapy has resulted in complete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60f7da0798a4d76f873a038ff617bf10
https://doi.org/10.1007/978-94-009-4273-8_16
https://doi.org/10.1007/978-94-009-4273-8_16
